FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Thompson Bruce E
2. Issuer Name and Ticker or Trading Symbol

EXACTECH INC [ EXAC ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Sr VP, Biologics & Spine
(Last)          (First)          (Middle)

3522 SW 92ND STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

9/1/2015
(Street)

GAINESVILLE, FL 32608
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   9/1/2015     M    2107   A $17.02   24887   D    
Common Stock   9/1/2015     S    2107   D $19.45   22780   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Option (right to buy)   $14.27                    12/18/2011   12/18/2016   Common Stock   5000     3814   D    
Incentive/Non-qualified Stock Option (right to buy)   $17.02   9/1/2015     M         2107    2/16/2013   2/16/2016   Common Stock   25000   $17.02   22893   D    
Incentive/Non-Qualified Stock Option (right to buy)   $18.95                    2/28/2014   2/28/2017   Common Stock   5900     5900   D    
Incentive/Non-Qualified Stock Option (right to buy)   $16.33                    2/22/2017   (1) 2/22/2019   Common Stock   23800     23800   D    
Incentive/Non-Qualified Stock Option (righ to buy)   $18.55                    2/25/2018   (2) 2/25/2020   Common Stock   20000     20000   D    
Non-Qualified Stock Option (right to buy)   $20.90                    5/9/2019   (3) 5/9/2021   Common Stock   12000     12000   D    
Non-Qualified Stock Option (right to buy)   $23.28                    4/29/2020   (4) 4/29/2022   Common Stock   9000     9000   D    

Explanation of Responses:
( 1)  Such options are currently exercisable as regards 14,280 of the covered shares. The remaining options are exercisable, as regards 4,760 of the covered shares on the fourth anniversary of the date of grant, and as regards 4,760 of the covered shares, on the fifth anniversary of the date of grant.
( 2)  Such options are currently exercisable as regards 8,000 of the covered shares. The remaining options are exercisable, as regards 4,000 of the covered shares, on the third anniversary of the date of grant, as regards 4,000 of the covered shares on the fourth anniversary of the date of grant, and as regards 4,000 of the covered shares, on the fifth anniversary of the date of grant.
( 3)  Such options are currently exercisable as regards 2,400 of the covered shares. The remaining options are exercisable, as regards 2,400 of the covered shares, on the second anniversary of the date of grant, as regards 2,400 of the covered shares, on the third anniversary of the date of grant, as regards 2,400 of the covered shares on the fourth anniversary of the date of grant, and as regards 2,400 of the covered shares, on the fifth anniversary of the date of grant.
( 4)  Such options are exercisable as regards 1,800 of the covered shares, on the first anniversary of the date of grant, as regards 1,800 of the covered shares, on the second anniversary of the date of grant, as regards 1,800 of the covered shares, on the third anniversary of the date of grant, as regards 1,800 of the covered shares on the fourth anniversary of the date of grant, and as regards 1,800 of the covered shares, on the fifth anniversary of the date of grant.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Thompson Bruce E
3522 SW 92ND STREET
GAINESVILLE, FL 32608


Sr VP, Biologics & Spine

Signatures
/s/ Bruce E. Thompson 9/3/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Exactech, Inc. (delisted) Charts.
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Exactech, Inc. (delisted) Charts.